Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aastrom raises $5 million for commercialisation:

This article was originally published in Clinica

Executive Summary

Aastrom Bioscienceshas raised $5 million in a private placement to a single investor, in order to begin the commercialisation of its AastromReplicell cell production system and commence of trials in the US. The funding will allow the Ann Arbor, Michigan-based company to begin production-stage manufacture of the stem cell replication system which will be used to increase blood and immune system function for cancer and blood disease patients.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT082948

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel